Horizon Therapeutics

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
At Horizon, we define our success by a different set of numbers: the number of lives touched, the number of lives changed, the number of lives saved.

As we build a growing pipeline and explore all potential uses for our medicines, we strive to make a powerful difference for our patients, their caregivers and physicians every day.

Our drive to deliver breakthrough therapies comes from our deep understanding of the patient journey. These patients’ courage inspires us – and drives us to listen, collaborate and build communities. That’s why, at our core, we believe science and compassion must work together to transform lives.

Founded in 2008 , Horizon now has over 1,200 employees focused on helping those impacted by rare and rheumatic conditions. Though we've grown, our culture is no different today than it was when we started. We remain personally invested in the lives of people our medicines help wherever they are in their journey, from diagnosis through ongoing care.
Ticker:
HZNP
Exchange:
NASDAQ
Company Type:
Not Provided
Company HQ State:
Illinois
Company HQ Country:
United States
Year Founded:
2008
Main Therapeutic Focus:
Lead Product in Development:
KRYSTEXXA
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Chief Strategy Officer
Horizon Therapeutics